Press release

Sideline RSV

A new health education campaign aimed to bring the conversation around the potential seriousness of Respiratory Syncytial Virus (RSV) center court for older adults.

Learn more about Sideline RSV

GSK’s Dr. Len Friedland, VP and Director of Scientific Affairs and Public Health for Sideline RSV

Close Video

Behind the science

Oncology

Gaining a deeper understanding of myelofibrosis – a rare blood cancer.

Women in science

Beth's mission is to make a molecule that becomes medicine — while helping others succeed.

The science of giving

Erica is driven by the need to pay forward and making a visible impact in our communities.

Women in science

Learn how Karen's remarkable teachers helped her find exactly where she belongs.

From football to pharmacy

DeWayne's dedication, teamwork and perseverance helps us meet patients where they are.

Financial Times Hub

Find articles, videos and learn about our latest tech and collaborations

Child in a unicorn costume standing with her mother

Women in science

Ann's early mentoring experience led her to become a "drug hunter" and a unicorn keeps her inspired.

Red Dab? Red Flag

Helping Black women spot endometrial cancer symptoms

Women in science

Meet Nicole and learn how her faith and natural curiosity guide her as a Medicinal Chemist.

Investors

We have announced our full year and Q4 2022 Results

Visit our global website for latest results

View all press releases

Three people seated around a table with laptops

GSKUS on twitter

#MultipleMyeloma survivor Thomas shares his story from diagnosis at a young age, to continued treatment, his role in clinical trials, and life as an advocate: gsk.to/3LMhvCG #MultipleMyelomaAwarenessMonth

Twitter @GSKUS Mar 23
Last summer the Moving Mountains for Multiple Myeloma #MM4MM team climbed Mount Washington to advocate for those with #MultipleMyeloma. This #MyelomaAwarenessMonth, we recognize all those who work tirelessly to positively impact the lives of people living with Multiple Myeloma.

Twitter @GSKUS Mar 22
We partner with the #HIV community to develop medicines that fit into people’s lives. Find out how we’re getting ahead of HIV together in the @FT gsk.to/FTHIVORG

Twitter @GSKUS Mar 22
We know that when people are truly themselves, we’re more innovative and deliver better outcomes for patients. Hear the stories of four of our amazing people. Learn more: gsk.to/3Z7C2Vb

Twitter @GSKUS Mar 22
March is #MyelomaAwarenessMonth! #MultipleMyeloma is the second most common form of blood cancer in the U.S. It’s more common in people aged >65 years old, men and African Americans. Learn more: gsk.to/3JUT1pt

Twitter @GSKUS Mar 20
We believe innovation starts when we stop to listen. Find out more about how we’re getting ahead of HIV together @FT gsk.to/FTHIVORG

Twitter @GSKUS Mar 17
Dana, Senior Specialty Account Specialist, Sales, and global lead for GSK’s Indigenous Peoples Association believes that having a diverse and multicultural workforce is vital to business success. Hear her story 👇N

Twitter @GSKUS Mar 16
#Lupus nephritis occurs when the immune system attacks and inflames the #kidneys, which can lead to permanent kidney damage. This National #KidneyMonth, develop a long-term disease management plan with your physician to help reduce risk.

Twitter @GSKUS Mar 15
We’re teaming up w/@MagicJohnson to help bring important conversations around the risks of #RSV among older adults center court. As a health advocate for more than 30 yrs, he will join #SidelineRSV to help raise awareness about the potential seriousness of #RSV for older adults.

Twitter @GSKUS Mar 14
We’re excited to announce #SidelineRSV! Together w/ @MagicJohnson, a Sideline RSV spokesperson, we’re committed to raising awareness about #RSV & the potential risk for severe infection in older adults & adults w/ underlying conditions like COPD, asthma or chronic heart failure.

Twitter @GSKUS Mar 14